Back to TEVA
Duquesne Family Office LLC → TEVA
Duquesne Family Office LLC TEVA Position History
Teva Pharmaceutical Industries Limited • Healthcare
Quarters held
8
Latest value
$21.2M
Q2 2026
Peak value
$335.2M
First seen
Q3 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2024 | $25.7M |
| Q4 2024 | $198.3M |
| Q1 2025 | $228.7M |
| Q2 2025 | $267.6M |
| Q3 2025 | $335.2M |
| Q4 2025 | $183.4M |
| Q1 2026 | $71.6M |
| Q2 2026 | $21.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $21.2M | 625.0K | — | — |
| Q1 2026 | $71.6M | 2.38M | — | — |
| Q4 2025 | $183.4M | 5.87M | — | — |
| Q3 2025 | $335.2M | 16.59M | — | — |
| Q2 2025 | $267.6M | 15.97M | — | — |
| Q1 2025 | $228.7M | 14.88M | — | — |
| Q4 2024 | $198.3M | 9.00M | — | — |
| Q3 2024 | $25.7M | 1.43M | — | — |
Other funds holding TEVA
$641.6M
$641.6M
$541.5M
$535.8M
$427.9M
$351.4M